ISRG
Baird took a little off the top
Robert W. Baird shaved its price target on Intuitive Surgical from $645 to $575 and kept the stock at Outperform. So yes, the analysts are dialing back the fairy dust a bit — but they’re still basically saying the robot surgeon has room to keep running.
Why investors should care
This is not the kind of note that screams “abandon ship.” It’s more like your favorite restaurant quietly raising prices while still being packed every night. The new target still suggests meaningful upside from the prior close, and that matters because sentiment around ISRG has been pretty resilient.
The earnings backdrop is doing the heavy lifting
The timing is important: Intuitive also just posted a strong quarter.
- EPS: $2.53 vs. $2.27 expected
- Revenue: $2.87 billion, up 18.8% year over year
- Street take: still a Moderate Buy on average, with a consensus target around $598.36
So while one analyst firm trimmed its target, the bigger picture is that the business is still growing like it has somewhere better to be.
The mixed analyst tape
Baird isn’t exactly alone in playing tug-of-war with the stock. Other firms have been tweaking targets too, which is analyst-speak for “we still like it, but we’re trying not to look too married to one number.”
Big picture: when a company can take a price-target cut and still keep investors mostly calm, that usually means the underlying story is doing the talking.